Fundamentally undervalued with a strong balance sheet, consistent earnings beats, and a low P/E ratio. Recent drop (~33% from 52-week highs) appears overdone relative to earnings strength likely due to short-term Medicaid cost concerns, not long-term deterioration.
📊 Position Type:
✅ Swing Trade to Core Position
Start small and build over time if technicals stabilize. Could evolve into a 6–12 month hold depending on market environment and how the stock reacts to future earnings or policy updates.
Entry Zone:
📍$380-360
📍$340
📍$300
Profit Targets
🎯 TP1: $415
🎯 TP2: $445
🎯 TP3: $500+
📌 Final Word
ELV is trading near a critical support zone after a 30% drop, yet it keeps delivering solid earnings. With strong cash flow and a powerful Carelon segment, this could be one of the best risk-reward setups in healthcare right now.
Disclaimer: This is not financial advice. Do your own research before investing.
📊 Position Type:
✅ Swing Trade to Core Position
Start small and build over time if technicals stabilize. Could evolve into a 6–12 month hold depending on market environment and how the stock reacts to future earnings or policy updates.
Entry Zone:
📍$380-360
📍$340
📍$300
Profit Targets
🎯 TP1: $415
🎯 TP2: $445
🎯 TP3: $500+
📌 Final Word
ELV is trading near a critical support zone after a 30% drop, yet it keeps delivering solid earnings. With strong cash flow and a powerful Carelon segment, this could be one of the best risk-reward setups in healthcare right now.
Disclaimer: This is not financial advice. Do your own research before investing.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.